[Event Report] Second Meeting of the “Rebalancing Healthcare Systems: Innovation and Sustainability” Taskforce: Measures to Effectively Control Costs for Research and Development and to Improve Market Access (November 18, 2019)
date : 12/15/2019
Tags: Future of the Health Care System, Innovation and Sustainability
HGPI held the second meeting of the “Rebalancing Healthcare Systems: Innovation and Sustainability” Taskforce on the topic of the “Measures to Effectively Control Costs for Research and Development and to Improve Market Access.”
Since the achievement of universal health coverage in 1961, the Japanese health system has supported the growth of the one of the healthiest and longest living populations in the world. As that population continues to age, Japan is being presented with a tremendous opportunity: to show the rest of the world how a super-aging society can successfully maintain a national health insurance system that works for all generations, and that can incorporate medical innovations and ensure healthy longevity even under circumstances in which members of the population regularly live to over 100-years of age.
As part of its “Rebalancing Healthcare Systems: Innovation and Sustainability” project, HPGI has formed a taskforce to debate policy measures that can support the achievement of such a system. This taskforce aims to produce an expert report on the health policy opportunities available to Japan within FY2020.
At this second taskforce meeting, taskforce members discussed the state of regulatory science in Japan, and the potential of policy measures in this field to increase access to medicine and improve the overall efficiency of the Japanese healthcare system.
■Overview
Date and time: Monday, November 18, 2019
Organizer: HGPI
■Program
Presentation “An Overview of Regulatory Science with a Particular Focus on Medical Devices and Equipment”
Mitsuo Umezu (Director, Institute for Medical Regulatory Science, Waseda University)
Taskforce Discussion
Taskforce Members (alphabetical order by last name):
Hirokazu Yoshii (Special Advisor to the President, Health Insurance Claims Review & Reimbursement Services)
Ataru Igarashi (Associate Professor, Unit of Public Health and Preventive Medicine, Yokohama City University of Medicine / Visiting Associate Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo / Fellow, HGPI)
Satoshi Imamura (Vice-President, Japan Medical Association)
Isao Kamae (Project Professor, Graduate School of Public Policy, The University of Tokyo)
Toshio Nagase (Senior Director, Government Affairs Japan, Gilead Science K.K.)
Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)
Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
Naokazu Saito (Director, Policy Intelligence Department, Janssen Pharmaceutical K.K.)
Mitsuo Umezu (Director, Institute for Medical Regulatory Science, Waseda University)
Observers:
Masami Sakoi (Assistant Minister, Minister’s Secretariat, Ministry of Health, Labour and Welfare (MHLW))
Kazumi Nishikawa (Director, Healthcare Industries Division, Ministry of Economy, Trade and Industry (METI))
Moderators (alphabetical order by last name):
Joji Sugawara (Senior Associate, HGPI)
Mitsuo Umezu (Director, Institute for Medical Regulatory Science, Waseda University)
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)